What Do You Know About Oxervate?

Marjan Farid, MD; Christopher J. Rapuano, MD; Kenneth A. Beckman, MD; Francis S. Mah, MD; and Marguerite B. McDonald, MD, share their experiences diagnosing and treating neurotrophic keratitis (NK) with Oxervate (cenegermin-bkbj). The physicians discuss common etiologies that lead to NK, what leads them to suspect the disease, and how Oxervate fits within current treatment options.

See Important Safety Information Below»

Supplement

Supplement Cover

Breakthrough Therapy for Neurotrophic Keratitis

Marjan Farid, MD; Christopher J. Rapuano, MD; Kenneth A. Beckman, MD; Francis S. Mah, MD; and Marguerite B. McDonald, MD, share their experiences diagnosing and treating neurotrophic keratitis (NK) with Oxervate (cenegermin-bkbj). The physicians discuss common etiologies that lead to NK, what leads them to suspect the disease, and how Oxervate fits within current treatment options.

Read Supplement »
Beckman Headshot

Kenneth A. Beckman, MD

Farid Headshot

Marjan Farid, MD

Mah Headshot

Francis S. Mah, MD

McDonald Headshot

Marguerite B. McDonald, MD

Rapuano Headshot

Christopher J. Rapuano, MD